Connor David, Rabbolini David, Morel-Kopp Marie-Christine, Fixter Kate, Donikian Dea, Kondo Mayuku, Chan Onki, Jarvis Susan, Chen Walter, Brighton Timothy, Chen Vivien, Ward Christopher, Joseph Joanne
St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.
St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Randwick, NSW, Australia.
Platelets. 2022 Nov 17;33(8):1139-1145. doi: 10.1080/09537104.2022.2052035. Epub 2022 Mar 22.
The use of mean platelet diameter (MPD) to classify inherited thrombocytopenia (IT) has been demonstrated in several studies. Alternatively, the mean platelet volume (MPV) may be used, but in macrothrombocytopenia this may not be available. We hypothesized that platelet forward scatter (FSC) measurements using flow cytometry may be used for the size-based classification of IT. The study aimed to assess the ability of platelet FSC to measure platelet size and whether it could be used as an alternative to the MPD or MPV.Blood samples were obtained from individuals undergoing investigation for inherited platelet function disorders (IPFD, n = 40) or platelet number disorders (IPND, n = 46). A hematology analyzer was used to obtain MPV and platelet counts, flow cytometry to measure platelet FSC and ImageJ software to measure MPD from stained blood smears. The International Society of Thrombosis and Hemostasis (ISTH) Bleeding Assessment Tool (BAT) was used to calculate bleeding scores.Twenty-nine(63%) of IPND patients had an MPV that could not be reported. A significant correlation to platelet FSC was found to the MPD (p < .0001) and MPV (p < .0001) and an inverse correlation with platelet count (p < .0001). No significant correlation was found between FSC and bleeding history. In conclusion, platelet FSC is an alternative to MPV and may be used in macrothrombocytopenia where the MPV is not recorded.
多项研究已证实,使用平均血小板直径(MPD)对遗传性血小板减少症(IT)进行分类。另外,也可使用平均血小板体积(MPV),但在巨血小板减少症中可能无法获取该指标。我们推测,利用流式细胞术测量的血小板前向散射(FSC)可用于基于大小的IT分类。本研究旨在评估血小板FSC测量血小板大小的能力,以及它是否可作为MPD或MPV的替代指标。
从因遗传性血小板功能障碍(IPFD,n = 40)或血小板数量障碍(IPND,n = 46)接受调查的个体中采集血样。使用血液分析仪获取MPV和血小板计数,流式细胞术测量血小板FSC,ImageJ软件从染色血涂片测量MPD。使用国际血栓与止血学会(ISTH)出血评估工具(BAT)计算出血评分。
29名(63%)IPND患者的MPV无法报告。发现血小板FSC与MPD(p <.0001)和MPV(p <.0001)显著相关,与血小板计数呈负相关(p <.0001)。未发现FSC与出血史之间存在显著相关性。总之,血小板FSC是MPV之外的另一种选择,可用于未记录MPV的巨血小板减少症。